- TOP
- Products
- Products and Services
- Pharmaceutical and Cosmetics
- Pharmaceuticals and Quasi-drugs (in-house products and CDMO)
Pharmaceuticals and Quasi-drugs (in-house products and CDMO)
Overview
Zonnebodo Pharmaceutical, a Nissha company, is a manufacture and a marketing authorization holder of pharmaceuticals and quasi-drugs. Nissha performs contract development of Oral Thin Films, and Zonnebodo Pharmaceutical plans to provide contract manufacturing of them.
By means of the Core Technologies as well as other innovations, Nissha aims to make a corporate social contribution to the pharmaceutical market, as it has in other markets, in such a way as to enrich people’s lives.
By means of the Core Technologies as well as other innovations, Nissha aims to make a corporate social contribution to the pharmaceutical market, as it has in other markets, in such a way as to enrich people’s lives.
In-house Products
Pharmaceuticals
- Mitigating tinnitus
- Vitamin B2 / B6
- Nicotinamide
Designated quasi-drugs
Quasi-drugs
- RENOVIGO (Fluoride spray toothpaste)
CDMO
Film type of pharmaceuticals
We have focused on the Drug Delivery System*, and proceeded with development of film type of pharmaceuticals (Oral Thin Films and Transdermal Patches). By utilizing our Core Technologies, we believe that we can contribute to improvements in dosage compliance and quality of life (QOL) for patients and aim for contribution to realize the enrichment of people’s lives.
*A dosing system designed for efficiently delivering the required amount of drug into the targeted site in the body for the required time.
*A dosing system designed for efficiently delivering the required amount of drug into the targeted site in the body for the required time.
Oral Thin Films
The thin film dissolves quickly in the mouth and is absorbed into the body. Since it be orally taken without water, and is suitable for elderly patients with swallowing difficulties and bedridden patients.
Transdermal Patches
The patch type formulation is applied to the skin, allowing the drug to penetrate directly into the bloodstream. It has a feature that is associated with less side effects mediated by hepatic metabolism.
Manufacturing base
Zonnebodo Pharmaceutical has manufacturing license for pharmaceuticals and GMP compliant manufacturing facilities with sophisticated manufacturing technologies and quality control capabilities in relation to a variety of drug forms, such as tablets, liquids and powders.
Site information
| Company name | Zonnebodo Pharmaceutical Co., Ltd. |
|---|---|
| Address | 5-7-14 Sandamachi, Hachioji, Tokyo 193-0832, Japan |
| Representative Director / CEO | Toshiyuki Yasui |
| Established | 1988 *Founded in 1941 |
| Business Outline | Manufacturing and marketing authorization holder of prescription pharmaceuticals and quasi drugs, marketing authorization holder of cosmetics |
| Licenses | ・Manufacturing license for pharmaceuticals ・Second-class marketing license for pharmaceuticals ・Selling license for pharmaceuticals（licenses for wholesale distribution） ・Manufacturing license for quasi-pharmaceutical products ・Marketing license for quasi-pharmaceutical products ・Marketing license for cosmetics |
| Website | https://www.zonnebodo.co.jp/ *Japanese only |
Inquiry
Please feel free to contact us.
